Stock comparison
Eli Lilly
Dr. Reddy's Laboratories Limited
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
RDY
Dr. Reddy's Laboratories Limited
Market cap
$11.32B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | RDY | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 57C | LLY |
| Benjamin Graham | 86A | 72B | LLY |
| Philip Fisher | 86A | 61C | LLY |
| Peter Lynch | 74B | 55C | LLY |
| Joel Greenblatt | 78C | 46D | LLY |
| Charlie Munger | 85A | 49D | LLY |
| Terry Smith | 77C | 45D | LLY |
Side-by-side metrics
| Metric | LLY | RDY |
|---|---|---|
| Market cap | $1T | $11.32B |
| P/E (TTM) | 36.6x | 26.0x |
| EV/EBIT | 34.1x | 24.0x |
| ROIC (TTM) | 32.06% | 8.07% |
| Gross margin | 83.51% | 52.77% |
| Net margin | 34.98% | 12.76% |
| Revenue CAGR 5y | 23.17% | 13.31% |
| EPS CAGR 5y | 40.81% | 17.36% |
| Debt / Equity | 1.4x | 0.2x |
| Dividend yield | 0.62% | 0.6% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Market cap$1Tvs $11.32B+99%
- ROIC (TTM)32.06%vs 8.07%+75%
- Net margin34.98%vs 12.76%+64%
- EPS CAGR 5y40.81%vs 17.36%+57%
RDY leads on
- Debt / Equity0.2xvs 1.4x+85%
- EV/EBIT24.0xvs 34.1x+29%
- P/E (TTM)26.0xvs 36.6x+29%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.